Selective tumor cell targeting by the disaccharide moiety of bleomycin.
about
Comprehensive evaluation of microRNA expression profiling reveals the neural signaling specific cytotoxicity of superparamagnetic iron oxide nanoparticles (SPIONs) through N-methyl-D-aspartate receptorBrain-targeted delivery of trans-activating transcriptor-conjugated magnetic PLGA/lipid nanoparticlesCodelivery of chemotherapeutics via crosslinked multilamellar liposomal vesicles to overcome multidrug resistance in tumorSymbiosis theory-directed green synthesis of silver nanoparticles and their application in infected wound healingThe disaccharide moiety of bleomycin facilitates uptake by cancer cellsInvestigation of the Chemical Changes from Crude and Processed Paeoniae Radix Alba-Atractylodis Macrocephalae Rhizoma Herbal Pair Extracts by Using Q Exactive High-Performance Benchtop Quadrupole-Orbitrap LC-MS/MS.Identification of alcohol-dependent clopidogrel metabolites using conventional liquid chromatography/triple quadrupole mass spectrometryThe carbamoylmannose moiety of bleomycin mediates selective tumor cell targeting.The use of fluorescently-tagged apoptolidins in cellular uptake and response studies.Microtubule-associated protein Mdp3 promotes breast cancer growth and metastasisImprovement of pharmacokinetic and antitumor activity of layered double hydroxide nanoparticles by coating with PEGylated phospholipid membrane.Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cellsModified bleomycin disaccharides exhibiting improved tumor cell targetingCrystal Structure of the Zorbamycin-Binding Protein ZbmA, the Primary Self-Resistance Element in Streptomyces flavoviridis ATCC21892BlmB and TlmB provide resistance to the bleomycin family of antitumor antibiotics by N-acetylating metal-free bleomycin, tallysomycin, phleomycin, and zorbamycin.Hairpin DNA sequences bound strongly by bleomycin exhibit enhanced double-strand cleavage.Fabrication of mAb G250-SPIO molecular magnetic resonance imaging nanoprobe for the specific detection of renal cell carcinoma in vitroFunctional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits.Simultaneous determination and pharmacokinetic study of gambogic acid and gambogenic acid in rat plasma after oral administration of Garcinia hanburyi extracts by LC-MS/MS.Polyethylene Oxide (PEO) and Polyethylene Glycol (PEG) Polymer Sieving Matrix for RNA Capillary Electrophoresis.Structural features facilitating tumor cell targeting and internalization by bleomycin and its disaccharide.Histamine-functionalized copolymer micelles as a drug delivery system in 2D and 3D models of breast cancer.A comprehensive review of glycosylated bacterial natural products.Delivery System of CpG Oligodeoxynucleotides through Eliciting an Effective T cell Immune Response against Melanoma in Mice.Loss of COX5B inhibits proliferation and promotes senescence via mitochondrial dysfunction in breast cancerMolecular-matched materials for anticancer drug delivery and imaging.SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy.Plug-and-playable fluorescent cell imaging modular toolkits using the bacterial superglue, SpyTag/SpyCatcher.Multifunctional nanoparticles: recent progress in cancer therapeutics.Carbohydrate nanocarriers in biomedical applications: functionalization and construction.The DNA sequence specificity of bleomycin cleavage in a systematically altered DNA sequence.Electrospun nanofibers for cancer diagnosis and therapy.Immune activity and biodistribution of polypeptide K237 and folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles radiolabeled with 99mTc.Active targeting of tumors through conformational epitope imprinting.A facile strategy to generate polymeric nanoparticles for synergistic chemo-photodynamic therapy.Nanoparticles inhibit cancer cell invasion and enhance antitumor efficiency by targeted drug delivery via cell surface-related GRP78.Novel biodegradable poly(propylene fumarate)-co-poly(l-lactic acid) porous scaffolds fabricated by phase separation for tissue engineering applicationsNovel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery.Metabolic engineering pathways for rare sugars biosynthesis, physiological functionalities, and applications-a review.The genome-wide DNA sequence specificity of the anti-tumour drug bleomycin in human cells.
P2860
Q28390339-40F8CCE5-D720-47D4-9211-32CBFC307C51Q28542784-785ECAEB-92AE-4B4C-B6AC-574598FA6F3DQ28543911-26B9B49F-A134-4A57-BEBA-BAD8D9F91803Q28829884-183428FD-10B6-40F5-90C6-D7271DE1F854Q30370964-72A43074-381F-4F0F-ACBF-85A11759F488Q33625333-E3786577-198F-4897-96DB-826D0D83CFBFQ33666595-F6FCA6CD-64AF-4439-8082-BEDF66E377AFQ33684947-8E41FA3D-862B-454E-A6B3-DAA602A8929DQ33920023-199DC443-4EDA-4BB2-9373-3A3C62EE26FFQ34086486-6DC73062-5C64-4DEB-82FC-3DE08836B955Q34415617-AB6E4599-BAB3-4E85-8088-4DCD66A31971Q34447234-C16056DB-DDF0-43FB-AA42-9BBFBF999BF5Q34463923-0ADB457D-683B-4076-9B41-A3529E7661AFQ34499818-97F24F28-E1BE-48AC-BC48-D14E3004A6B1Q34502778-C742D685-A49C-4D54-B88E-E7E909546170Q35096646-6DFA54AA-F721-4CF4-8F6A-0006F0B3F4F6Q35202263-83D4F097-9B1C-4F76-B38B-10366D47DF33Q35206829-52E780F7-1577-4CAF-8D7D-846F0C60E6FDQ35232539-F6BFDA09-A6E6-4423-B286-7434011C6116Q35560953-426BF8A9-F7AA-4085-94F2-D0273149F27BQ35633948-88E9D971-AE3B-4F35-99CF-3680C1686E6CQ35741040-1FFEDF29-2576-4F45-BCB9-09FB768FAF0DQ36029831-DC051DED-CA8B-472B-BC94-6DC70C88BFA6Q36563884-21872C9D-95AD-4D2D-BA2F-607A26DCCA7FQ36685411-914FB8AC-EF66-40D2-AC54-930B5759F07EQ37013374-62840432-1B47-4215-A2E5-0BBAC57EA76DQ37476025-BB1181CD-6A2F-4707-8FE4-CF6F0680011EQ38408571-A55F43F3-7AEF-4C1A-BBCA-F4CDECAF4241Q38559193-7CB703FB-50BB-4885-BB82-F28EE2702BF6Q38567851-40555CF3-A3E2-43F1-918F-F3AAAF5785B3Q38783137-3C43F752-242C-4E3F-8115-0070D3C9E441Q38799169-58BA36CE-41E9-448F-8EFA-4FFDF0FA2AA8Q38803180-6ADEE09E-9CB2-41E9-8AF5-2BF21A2E2A7FQ38904994-F87C1384-2539-404A-8AF7-EC7B46577EF8Q38910610-81C04D63-0E09-4F0C-8635-C57CD5A4D384Q38922439-5C06B439-F4CB-4AD4-B8F6-D97F2EA0C11DQ39011457-D4E415BA-7EE3-4384-94CD-FA0FA1F5D379Q39036547-5BAA3A99-24D5-4792-B4C2-33AEF3FB92CBQ39405167-442FCF7C-D3BB-455E-8D6F-A7BC580ADFB5Q39759582-EDAE1141-903E-4496-B848-B049752A5703
P2860
Selective tumor cell targeting by the disaccharide moiety of bleomycin.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Selective tumor cell targeting by the disaccharide moiety of bleomycin.
@ast
Selective tumor cell targeting by the disaccharide moiety of bleomycin.
@en
type
label
Selective tumor cell targeting by the disaccharide moiety of bleomycin.
@ast
Selective tumor cell targeting by the disaccharide moiety of bleomycin.
@en
prefLabel
Selective tumor cell targeting by the disaccharide moiety of bleomycin.
@ast
Selective tumor cell targeting by the disaccharide moiety of bleomycin.
@en
P2093
P2860
P356
P1476
Selective tumor cell targeting by the disaccharide moiety of bleomycin.
@en
P2093
Krystal S Tsosie
Michael J Rishel
Rakesh Paul
Ryan M Schmaltz
Sidney M Hecht
Trevor C Bozeman
Zhiqiang Yu
P2860
P304
P356
10.1021/JA311090E
P407
P577
2013-02-13T00:00:00Z